Collaborators GDaIIaP (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7
Zheng SL, Chan FT, Nabeebaccus AA, Shah AM, McDonagh T, Okonko DO, Ayis S (2018) Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart 104(5):407–415. https://doi.org/10.1136/heartjnl-2017-311652
Article CAS PubMed Google Scholar
Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J (2018) Effects of spironolactone in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 97(35):e11942. https://doi.org/10.1097/MD.0000000000011942
Article CAS PubMed Google Scholar
Martin N, Manoharan K, Davies C, Lumbers RT (2021) Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev 5:CD012721. https://doi.org/10.1002/14651858.CD012721.pub3
Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-Caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-Migaj E, McDonagh T, Seferovic P, Ruschitzka F (2018) Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20(11):1505–1535. https://doi.org/10.1002/ejhf.1236
Bonnemain J, Del Nido PJ, Roche ET (2022) Direct cardiac compression devices to augment heart biomechanics and function. Annu Rev Biomed Eng 24:137–156. https://doi.org/10.1146/annurev-bioeng-110220-025309
Article CAS PubMed Google Scholar
Burzotta F, Russo G, Previ L, Bruno P, Aurigemma C, Trani C (2018) Impella: pumps overview and access site management. Minerva Cardioangiol 66(5):606–611. https://doi.org/10.23736/S0026-4725.18.04703-5
Lüsebrink E, Kellnar A, Krieg K, Binzenhöfer L, Scherer C, Zimmer S, Schrage B, Fichtner S, Petzold T, Braun D, Peterss S, Brunner S, Hagl C, Westermann D, Hausleiter J, Massberg S, Thiele H, Schäfer A, Orban M (2022) Percutaneous transvalvular microaxial flow pump support in cardiology. Circulation 145(16):1254–1284. https://doi.org/10.1161/CIRCULATIONAHA.121.058229
Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588. https://doi.org/10.1016/j.jacc.2008.05.065
O’Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M (2012) A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126(14):1717–1727. https://doi.org/10.1161/CIRCULATIONAHA.112.098194
Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BAJM, Tijssen JGP, Henriques JPS (2017) Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69(3):278–287. https://doi.org/10.1016/j.jacc.2016.10.022
Schrage B, Ibrahim K, Loehn T, Werner N, Sinning J-M, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D, Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke J-T, Møller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Möbius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S, Thiele H, Schäfer A, Westermann D (2019) Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 139(10):1249–1258. https://doi.org/10.1161/CIRCULATIONAHA.118.036614
Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, Ngufor C, Girotra S, Amin AP, Shah ND, Desai NR (2020) Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 323(8):734–745. https://doi.org/10.1001/jama.2020.0254
Article PubMed PubMed Central Google Scholar
Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296. https://doi.org/10.1056/NEJMoa1208410
Article CAS PubMed Google Scholar
Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382(9905):1638–1645. https://doi.org/10.1016/S0140-6736(13)61783-3
Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S (2010) Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 304(8):867–874. https://doi.org/10.1001/jama.2010.1190
Article CAS PubMed Google Scholar
Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, Gurley J, Nelson K, Malyala R, Panjrath GS, Zwischenberger JB, Pinney SP (2019) Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 73(6):698–716. https://doi.org/10.1016/j.jacc.2018.11.038
Schrage B, Burkhoff D, Rübsamen N, Becher PM, Schwarzl M, Bernhardt A, Grahn H, Lubos E, Söffker G, Clemmensen P, Reichenspurner H, Blankenberg S, Westermann D (2018) Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock. JACC Heart Fail 6(12):1035–1043. https://doi.org/10.1016/j.jchf.2018.09.009
Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Greco T, Lembo R, Müllerleile K, Colombo A, Sydow K, De Bonis M, Wagner F, Reichenspurner H, Blankenberg S, Zangrillo A, Westermann D (2017) Concomitant implantation of Impella on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 19(3):404–412. https://doi.org/10.1002/ejhf.668
Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, Colson P, Cudemus Deseda G, Dabboura S, Eckner D, Eden M, Eitel I, Frank D, Frey N, Funamoto M, Goßling A, Graf T, Hagl C, Kirchhof P, Kupka D, Landmesser U, Lipinski J, Lopes M, Majunke N, Maniuc O, McGrath D, Möbius-Winkler S, Morrow DA, Mourad M, Noel C, Nordbeck P, Orban M, Pappalardo F, Patel SM, Pauschinger M, Pazzanese V, Reichenspurner H, Sandri M, Schulze PC, Schwinger RHG, Sinning J-M, Aksoy A, Skurk C, Szczanowicz L, Thiele H, Tietz F, Varshney A, Wechsler L, Westermann D (2020) Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study. Circulation 142(22):2095–2106. https://doi.org/10.1161/CIRCULATIONAHA.120.048792
Article CAS PubMed PubMed Central Google Scholar
Tongers J, Sieweke J-T, Kühn C, Napp LC, Flierl U, Röntgen P, Schmitto JD, Sedding DG, Haverich A, Bauersachs J, Schäfer A (2020) Early escalation of mechanical circulatory support stabilizes and potentially rescues patients in refractory cardiogenic shock. Circ Heart Fail 13(3):e005853. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005853
Carubelli V, Metra M, Lombardi C, Bettari L, Bugatti S, Lazzarini V, Dei Cas L (2012) Renal dysfunction in acute heart failure: epidemiology mechanisms and assessment. Heart Fail Rev 17(2):271–282. https://doi.org/10.1007/s10741-011-9265-z
Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47(10):1987–1996
Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TDJ, Cleland JGF, van Veldhuisen DJ, Hillege HL (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13(8):599–608
Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35(7):455–469. https://doi.org/10.1093/eurheartj/eht386
Annamalai SK, Esposito ML, Reyelt LA, Natov P, Jorde LE, Karas RH, Kapur NK (2018) Abdominal positioning of the next-generation intra-aortic fluid entrainment pump (Aortix) improves cardiac output in a swine model of heart failure. Circ Heart Fail 11(8):e005115. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005115
Article PubMed PubMed Central Google Scholar
Shabari FR, George J, Cuchiara MP, Langsner RJ, Heuring JJ, Cohn WE, Hertzog BA, Delgado R (2013) Improved hemodynamics with a novel miniaturized intra-aortic axial flow pump in a porcine model of acute left ventricular dysfunction. ASAIO J 59(3):240–245. https://doi.org/10.1097/MAT.0b013e31828a6e74
Vora AN, Schuyler Jones W, DeVore AD, Ebner A, Clifton W, Patel MR (2019) First-in-human experience with Aortix intraaortic pump. Catheter Cardiovasc Interv 93(3):428–433. https://doi.org/10.1002/ccd.27857
Dierckx R, Vanderheyden M, Heggermont W, Goethals M, Verstreken S, Bartunek J (2019) Treatment of diuretic resistance with a novel percutaneous blood flow regulator: concept and initial experience. J Card Fail 25(11):932–934. https://doi.org/10.1016/j.cardfail.2019.08.017
Kapur NK, Karas RH, Newman S, Jorde L, Chabrashvili T, Annamalai S, Esposito M, Kimmelstiel CD, Lenihan T, Burkhoff D (2019) First-in-human experience with occlusion of the superior vena cava to reduce cardiac filling pressures in congestive heart failure. Catheter Cardiovasc Interv 93(7):1205–1210. https://doi.org/10.1002/ccd.28326
Article PubMed PubMed Central Google Scholar
Kapur NK, Reyelt L, Crowley P, Richey L, McCarthy J, Annamalai S, Newman S, Jorde L, Forotuanjazi S, Razavi A, Lenihan T, Burkhoff D, Karas RH (2020) Intermittent occlusion of the superior vena cava reduces cardiac filling pressures in preclinical models of heart failure. J Cardiovasc Transl Res 13(2):151–157. https://doi.org/10.1007/s12265-019-09916-y
Kapur NK, Kiernan MS, Gorgoshvili I, Yousefzai R, Vorovich EE, Tedford RJ, Sauer AJ, Abraham J, Resor CD, Kimmelstiel CD, Benzuly KH, Steinberg DH, Messer J, Burkhoff D, Karas RH (2022) Intermittent occlusion of the superior vena cava to improve hemodynamics in patients with acutely decompensated heart failure: the VENUS-HF early feasibility study. Circ Heart Fail 15(2):e008934
留言 (0)